CRVO - CervoMed - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRVO is currently covered by 5 analysts with an average price target of $36.57. This is a potential upside of $28.32 (343.27%) from yesterday's end of day stock price of $8.25.

CervoMed's activity chart (see below) currently has 0 price targets and 17 ratings on display. The stock rating distribution of CRVO is 76.47% BUY and 23.53% HOLD.

Stock Analyst Price Targets - Review

Highest price target for CRVO is $27, Lowest price target is $10, average price target is $18.5.

Most recent stock forecast was given by SUMANT KULKARNI from CANACCORD on 29-Jul-2025. First documented stock forecast 15-Feb-2024.

Best performing analysts who are covering CRVO - CervoMed:

Sumant Kulkarni Jason Kolbert Daniil Gataulin Raghuram Selvaraju Soumit Roy

Currently out of the existing stock ratings of CRVO, 13 are a BUY (76.47%), 4 are a HOLD (23.53%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$27

$18.75 (227.27%)

4 days ago
(29-Jul-2025)

0/4 (0%)

$18.58 (220.67%)

Buy

$10

$1.75 (21.21%)

$10

5 days ago
(28-Jul-2025)

0/5 (0%)

$1.33 (15.34%)

Hold

$42

7 months 16 days ago
(17-Dec-2024)

0/1 (0%)

$32.28 (332.10%)

Hold

$55

7 months 22 days ago
(11-Dec-2024)

0/1 (0%)

$39.2 (248.10%)

Hold

$70

7 months 23 days ago
(10-Dec-2024)

0/1 (0%)

$50.23 (254.07%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRVO (CervoMed) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CRVO (CervoMed) with a proven track record?

SUMANT KULKARNI

Which analyst has the current lower performing score on CRVO (CervoMed) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on CRVO (CervoMed)?

Sumant Kulkarni works at CANACCORD and has 9 price targets and 9 ratings on CRVO

Which analyst is the currently most bullish on CRVO (CervoMed)?

Sumant Kulkarni with highest potential upside - $18.75

Which analyst is the currently most reserved on CRVO (CervoMed)?

Daniil Gataulin with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?